KITLG and acute myeloid leukemia: One potential target for AML is CD123, an IL-3 receptor alpha chain that acts as a high-affinity receptor for stem cell factor (SCF) and is expressed at low levels in early hematopoietic cells, such as hematopoietic stem/progenitor cells (HSPCs) (96).